Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial.
about
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (afternoon panel discussion).
P2860
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@ast
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en-gb
type
label
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@ast
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en-gb
prefLabel
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@ast
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en-gb
P2093
P2860
P50
P1154
2-s2.0-84953363266
P1476
Pre-trial inter-laboratory ana ...... S4 personalised therapy trial.
@en
P2093
Bharat Jasani
Cheryl Pugh
FOCUS4 Trial Management Group
Gemma Hemmings
Helen Roberts
Michelle D James
Phil Chambers
Phil Quirke
Rachel Butler
Sue Wozniak
P2860
P356
10.1136/JCLINPATH-2015-203097
P407
P5530
P577
2015-09-07T00:00:00Z
P5875
P6179
1025613657